{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:40:24Z","timestamp":1787319624013,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"DOI":"10.7759\/cureus.114921","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:50:24Z","timestamp":1787316624000},"source":"Crossref","is-referenced-by-count":0,"title":["High-Altitude Headache Resolving After Self-Administration of Goreisan: A Case Report"],"prefix":"10.7759","author":[{"given":"Masahito","family":"Katsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Gutierrez-Arratia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Piero Lastarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Obesso Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Matsumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1113\/JP289704","article-title":"High-altitude headache: insights into pathophysiology and potential treatment implications","author":"Falla M","year":"2026","unstructured":"Falla M, Frank F, Strapazzon G, Lawley J. High-altitude headache: insights into pathophysiology and potential treatment implications. J Physiol. 2026, 10.1113\/JP289704","journal-title":"J Physiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab102","article-title":"Risk factors for acute mountain sickness in travellers to Cusco, Peru: coca leaves, obesity and sex","volume":"29","author":"Caravedo MA","year":"2022","unstructured":"Caravedo MA, Mozo K, Morales ML, Smiley H, Stuart J, Tilley DH, Cabada MM. Risk factors for acute mountain sickness in travellers to Cusco, Peru: coca leaves, obesity and sex. J Travel Med. 2022, 29:102. 10.1093\/jtm\/taab102","journal-title":"J Travel Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","article-title":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition","volume":"38","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38.1-211. 10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410394678","article-title":"Risk factors for high-altitude headache in mountaineers","volume":"31","author":"Burtscher M","year":"2011","unstructured":"Burtscher M, Mairer K, Wille M, Broessner G. Risk factors for high-altitude headache in mountaineers. Cephalalgia. 2011, 31:706-11. 10.1177\/0333102410394678","journal-title":"Cephalalgia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.111777","article-title":"Evaluation of the efficacy of pharmacological interventions in the prevention of acute mountain sickness: a network meta-analysis","volume":"18","author":"Sarma I","year":"2026","unstructured":"Sarma I, Buragohain S, Lahon J, Meenu M, Mohapatra S, Saikia D. Evaluation of the efficacy of pharmacological interventions in the prevention of acute mountain sickness: a network meta-analysis. Cureus. 2026, 18:e111777. 10.7759\/cureus.111777","journal-title":"Cureus"},{"key":"ref6","article-title":"Clinical Practice Guideline for Headache Disorders 2021 (Book in Japanese)","author":"Headache Clinical Practice Guideline Development Committee","year":"2021","unstructured":"Headache Clinical Practice Guideline Development Committee. Clinical Practice Guideline for Headache Disorders 2021 (Book in Japanese). Japanese Society of Neurology, Japanese Headache Society, Japanese Society of Neurological Therapeutics (ed): Igaku-Shoin, Tokyo; 2021."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2023.12.001","article-title":"Goreisan regulates cerebral blood flow according to barometric pressure fluctuations in female C57BL\/6J mice","volume":"154","author":"Kurauchi Y","year":"2024","unstructured":"Kurauchi Y, Ryu S, Tanaka R, et al.. Goreisan regulates cerebral blood flow according to barometric pressure fluctuations in female C57BL\/6J mice. J Pharmacol Sci. 2024, 154:47-51. 10.1016\/j.jphs.2023.12.001","journal-title":"J Pharmacol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.010","article-title":"Goreisan prevents brain edema after cerebral ischemic stroke by inhibiting aquaporin 4 upregulation in mice","volume":"27","author":"Nakano T","year":"2018","unstructured":"Nakano T, Nishigami C, Irie K, et al.. Goreisan prevents brain edema after cerebral ischemic stroke by inhibiting aquaporin 4 upregulation in mice. J Stroke Cerebrovasc Dis. 2018, 27:758-63. 10.1016\/j.jstrokecerebrovasdis.2017.10.010","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/tkm2.1380","article-title":"Goreisan alleviates cerebral edema: possibility of its involvement in inhibiting aquaporin-4 function","volume":"10","author":"Shimizu T","year":"2023","unstructured":"Shimizu T, Murakami K, Matsumoto C, Kido T, Isohama Y. Goreisan alleviates cerebral edema: possibility of its involvement in inhibiting aquaporin-4 function. Trad Kampo Med. 2023, 10:168-76. 10.1002\/tkm2.1380","journal-title":"Trad Kampo Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1248\/bpbreports.8.5_128","article-title":"Clinical response to premonitory-phase Goreisan therapy in migraine with weather- and barometric pressure-related headache","volume":"8","author":"Ishii M","year":"2025","unstructured":"Ishii M, Ito I, Katoh H. Clinical response to premonitory-phase Goreisan therapy in migraine with weather- and barometric pressure-related headache. BPB Reports. 2025, 8:128-32. 10.1248\/bpbreports.8.5_128","journal-title":"BPB Reports"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1023\/A:1026119331193","article-title":"A six-item short-form survey for measuring headache impact: the HIT-6","volume":"12","author":"Kosinski M","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB, et al.. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003, 12:963-74.","journal-title":"Qual Life Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410379890","article-title":"Validation of the Headache Impact Test (HIT-6\u2122) across episodic and chronic migraine","volume":"31","author":"Yang M","year":"2011","unstructured":"Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6\u2122) across episodic and chronic migraine. Cephalalgia. 2011, 31:357-67. 10.1177\/0333102410379890","journal-title":"Cephalalgia"},{"key":"ref13","article-title":"Development and validation of the Migraine Interictal Burden Scale (MIBS): a self-administered instrument for measuring the burden of migraine between attacks","volume":"68 (Suppl 1)","author":"Buse D","year":"2007","unstructured":"Buse D, Bigal MB, Rupnow M, Reed M, Serrano D, Lipton R. Development and validation of the Migraine Interictal Burden Scale (MIBS): a self-administered instrument for measuring the burden of migraine between attacks. Neurology. 2007, 68 (Suppl 1):A89.","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01467-z","article-title":"Measuring interictal burden among people affected by migraine: a descriptive survey study","volume":"23","author":"Hubig LT","year":"2022","unstructured":"Hubig LT, Smith T, Williams E, et al.. Measuring interictal burden among people affected by migraine: a descriptive survey study. J Headache Pain. 2022, 23:97. 10.1186\/s10194-022-01467-z","journal-title":"J Headache Pain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2026.104260","article-title":"Biomarkers and potential subtypes of acute mountain sickness: a state-of-the-science review","volume":"95","author":"Burtscher J","year":"2026","unstructured":"Burtscher J, Ehlers R, Bourdillon N, Pircher N\u00f6ckler ER, Gatterer H, H\u00fcfner K, Gostner JM. Biomarkers and potential subtypes of acute mountain sickness: a state-of-the-science review. Redox Biol. 2026, 95:104260. 10.1016\/j.redox.2026.104260","journal-title":"Redox Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600169","article-title":"Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache","volume":"26","author":"Bailey DM","year":"2006","unstructured":"Bailey DM, Roukens R, Knauth M, et al.. Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab. 2006, 26:99-111. 10.1038\/sj.jcbfm.9600169","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2013.83","article-title":"Investigation of whole-brain white matter identifies altered water mobility in the pathogenesis of high-altitude headache","volume":"33","author":"Lawley JS","year":"2013","unstructured":"Lawley JS, Oliver SJ, Mullins PG, Macdonald JH. Investigation of whole-brain white matter identifies altered water mobility in the pathogenesis of high-altitude headache. J Cereb Blood Flow Metab. 2013, 33:1286-94. 10.1038\/jcbfm.2013.83","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.02.013","article-title":"Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial","volume":"260","author":"Yaku H","year":"2023","unstructured":"Yaku H, Kato T, Morimoto T, et al.. Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial. Am Heart J. 2023, 260:18-25. 10.1016\/j.ahj.2023.02.013","journal-title":"Am Heart J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.57364\/jnkm.4.1_9","article-title":"Clinical analysis of the patients with primary headache in whom Goreisan is effective (Article in Japanese)","volume":"4","author":"Shibata Y","year":"2018","unstructured":"Shibata Y. Clinical analysis of the patients with primary headache in whom Goreisan is effective (Article in Japanese). J Neurosurg Kampo Med. 2018, 4:9-13. 10.57364\/jnkm.4.1_9","journal-title":"J Neurosurg Kampo Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/524991-high-altitude-headache-resolving-after-self-administration-of-goreisan-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:50:25Z","timestamp":1787316625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/524991-high-altitude-headache-resolving-after-self-administration-of-goreisan-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.114921","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}